Plain-English translation of NCT06833060 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new laser device called the ELLEX TSLT system to treat glaucoma and high eye pressure. Unlike older laser treatments, this device works through the white part of the eye rather than requiring contact with the clear front surface, which may make the procedure simpler and safer for both patients and doctors.
Current laser treatments for glaucoma require placing a lens directly on the eye, which can cause complications and discomfort. This trial exists to see whether the new treatment approach—working without touching the front of the eye—can be safer and easier while still effectively lowering eye pressure.
You likely qualify if…
You likely don't qualify if…
You will attend four study visits over about 2 months. At your first visit, the doctor will evaluate your eye condition. At the second visit, you will receive the new laser treatment. Then you'll return for follow-up visits at 1 day and 30 days after treatment so the research team can check whether the treatment worked and ensure you're safe.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Australia